YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Rituxan

Third Rituxan Patient Diagnosed with PML

Oct 26, 2009 | Parker Waichman Alonso LLP
A third Rituxan patient has developed a serious and often fatal brain infection called progressive multifocal leukoencephalopathy (PML).  ...

Rituxan - PML Link Could Spark FDA Action

Jun 1, 2009 | Parker Waichman Alonso LLP
U.S. health regulators are taking a look at the lymphoma drug Rituxan because of its possible association with progressive multifocal...

Study Finds 57 Rituxan Patients Developed PML

May 20, 2009 | Parker Waichman Alonso LLP
Patients taking Rituxan may be at risk of developing a serious, and often fatal brain infection called progressive multifocal leukoencephalitis...

Rituxan Treatment for Rheumatoid Arthritis Implicated in Brain Infection

Sep 11, 2008 | Parker Waichman Alonso LLP
The labeling for Rituxan is being revised following a report that a patient administered the drug to treat rheumatoid arthritis had died of the brain...

Rituxan Therapy Linked to Fatal Brain Infection

Aug 14, 2007 | Parker Waichman Alonso, LLP
Rituxan, a powerful cancer medication, has been linked to a fatal brain infection called progressive multifocal leukoencephalopathy (PML).  PML...

Biotech firms' drug is linked to deaths

Dec 19, 2006 | Los Angeles Times
The bestselling medicine for two of the country's biggest biotech drug companies has been further linked to a rare and deadly brain infection, U.S....

Biogen, Genentech issue warning for Rituxan

Dec 19, 2006 | www.cbsmarketwatch.com
Biogen Idec and Genentech have issued a warning to healthcare providers for their oncology drug Rituxan, advising them that the drug has been linked...

Rituxan (rituxamab) Linked to Two Deaths in Lupus Patients

Dec 19, 2006 | www.medpagetodaycom
Two patients treated with the immune modulator Rituxan (rituximab) for systemic lupus erythmatosus (SLE) have died of progressive multifocal...

Off-Label Use of Rituxan Linked to Fatal Leukoencephalopathy

Dec 19, 2006 | www.medscape.com
The US Food and Drug Administration (FDA) is warning healthcare professionals regarding the risk for progressive multifocal leukoencephalopathy (PML)...

Rituxan warning issued by FDA

Dec 19, 2006 | North County Times
Patients treated with Rituxan may be at risk from a rare, fatal brain infection, the U.S. Food and Drug Administration warned Monday. The FDA said...

Page 1/2 [first] [prev] 1 2 [next] [last]

Defective Drugs
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Name of drug:

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News